Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OrthopoxVac (VACΔ6) vaccine for smallpox and orthopoxvirus infections
NCT05846243Phase 3Completed
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of OrthopoxVac in smallpox, mpox, cowpox, vaccinia virus infection. Started Oct 2021; status: completed.
02
Drugs
OrthopoxVac
03
Conditions
smallpoxmpoxcowpoxvaccinia virus infection
Beyond the preview
Go deeper on NCT05846243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05846243.